A Randomized Phase III Study of a Cisplatin (CDDP) and Docetaxel (DOC) with or without Irinotecan (CPT) in Patients with Advanced NSCLC: Okayama Lung Cancer Study Group OLCSG 0403 Trial
Keyword(s):
2010 ◽
Vol 28
(15_suppl)
◽
pp. 7597-7597
◽
Keyword(s):
2005 ◽
Vol 23
(16_suppl)
◽
pp. 7016-7016
◽
Keyword(s):
2010 ◽
Vol 28
(15_suppl)
◽
pp. 7584-7584
Keyword(s):
Keyword(s):
2000 ◽
Vol 36
(1)
◽
pp. 3-8
◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 21
(1)
◽
pp. 81-87
◽
Keyword(s):